Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Argonne Capital Group is a private equity firm headquartered in Atlanta, Georgia, that focuses on equity investments in middle-market enterprises. Founded in 2003 by Michael Klump, the firm distinguishes itself by independently capitalizing each transaction, which provides significant flexibility in deal structure and an indefinite ownership horizon. While the firm is well-known for its large-scale investments in the restaurant and retail sectors, it also maintains a dedicated focus on healthcare services and medical equipment. Notable healthcare-related activity includes its investment in InfuSystem Holdings, a leading provider of infusion pumps and clinical services, and the firm's leadership has held board positions in biotechnology companies such as CytoDyn. Argonne typically targets companies with strong cash flows and significant real estate assets, leveraging its expertise to accelerate growth and operational efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Argonne Capital Group.